The efficacy and safety of 10 mg/day vortioxetine compared to placebo for adult major depressive disorder: a meta-analysis

BACKGROUND: There is a growing interest in vortioxetine in major depressive disorder (MDD). OBJECTIVES: This meta-analysis aimed to assess the efficacy and safety of 10 mg/day (mg/d) vortioxetine compared to placebo for MDD in adult. METHODS: Eight randomly controlled trials (RCTs) about the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jiahuan, Wang, Zhaoyu, Li, Enli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531944/
https://www.ncbi.nlm.nih.gov/pubmed/31149002
http://dx.doi.org/10.4314/ahs.v19i1.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531944/
https://www.ncbi.nlm.nih.gov/pubmed/31149002
http://dx.doi.org/10.4314/ahs.v19i1.48

Ejemplares similares